Results 121 to 130 of about 418,457 (205)

CRISPR-based functional genomics for dissecting therapeutic dependency in primary acute myeloid leukemia samples. [PDF]

Mol Cell
Cao Z, Yu S, Peng J, Barrett DR, Liu Y, Sussman JH, Chen C, Thadi A, Liu L, Alikarami F, Xu J, Carroll MP, Tan K, Bernt KM, Shi J.   +14 more
europepmc   +1 more source

Species barriers in AAV tropism: mechanisms, models, and emerging solutions for clinical translation. [PDF]

Acta Biochim Pol
Xu X.
europepmc   +1 more source

Ciliopathies in Complex Congenital Heart Disease: Molecular Genetics, Embryologic Mechanisms and Clinical Implications. [PDF]

Genes (Basel)
Gagliardi MF, Micaglio E, Micheletti A, Benedetti S, Giordano A, Alonzo BM, Guglielmi G, Negura DG, Giamberti A, Chessa M.   +9 more
europepmc   +1 more source

Revisiting viral reprogramming: Measles virus as a robust platform for high-quality iPSC generation. [PDF]

Mol Ther Adv
Moutaoufik MT, Chahine M.
europepmc   +1 more source

Engineering precision oncology: Targeting tumors and immune cells with lentiviral vectors. [PDF]

Mol Ther Oncol
Rossi J, Martinello C, Sorrentino R, Guyonnet-Duperat V, Amintas S, Abrey Recalde MJ, Verhoeyen E, Dabernat S.   +7 more
europepmc   +1 more source

Proteomics in myelodysplastic syndromes: towards novel prognostic and diagnostic biomarkers. [PDF]

Biochem Med (Zagreb)
Novak R, Mandac Smoljanović I, Grgurević L.   +2 more
europepmc   +1 more source

The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects. [PDF]

Signal Transduct Target Ther
Lu J, Cui J, Dong J, Yan L, Wang X, Zhou D, Lu S, Wei W.   +7 more
europepmc   +1 more source

Targeting Horizontal Gene Transfer to Combat Antimicrobial Resistance: A Review of Mechanisms, Drivers, and Multi-Omics Strategies. [PDF]

Infect Drug Resist
Tang L, Yang W, Yang L, Lv Y, Zhang J.
europepmc   +1 more source

Synthesis of Programmable Bioelectronic Yeast for Biohybrid Futures. [PDF]

Eng Biol
Erpf PE, Kinder BD, Archer E, Walker RSK, Pretorius IS, Paulsen IT.   +5 more
europepmc   +1 more source

Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy. [PDF]

Cancer Res
Wang R, Yu J, Caligiuri MA, Ma S.
europepmc   +1 more source